Faruqi & Faruqi, LLP is Investigating PetMed Express, Inc. (PETS) on Behalf of its Shareholders

NEW YORK, NY / ACCESSWIRE / August 24, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at PetMed Express, Inc. (”PetMed” or the ”Company”) (NASDAQ: PETS).

The investigation focuses on whether the Company’s Board of Directors and/or its officers committed mismanagement and breached their fiduciary duties. On August 23, 2017, Aurelius Value published a report claiming that PetMed, an online veterinary pharmacy, engaged in an extensive online advertising campaign to ”aggressively market dangerous painkillers to human opiate addicts and drug users.”

Request more information now by clicking here: www.faruqilaw.com/PETS. There is no cost or obligation to you.

Take Action

If you currently own PetMed stock and have continuously owned PetMed stock and would like to discuss your legal rights, please visit www.faruqilaw.com/PETS. You can also contact us by calling Nina Varindani or Stuart Guber toll free at (212) 983-9330 or by sending an e-mail to nvarindani@faruqilaw.com or sguber@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding PetMed’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
685 3rd Avenue, 26th Floor
New York, NY 10017

Attn: Nina Varindani
nvarindani@faruqilaw.com
Telephone: (212) 983-9330

Attn: Stuart Guber
sguber@faruqilaw.com
Telephone: (215) 277-5770

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 473569